ZIOPHARM Oncology, Inc. ZIOP
$ 1.22
-7.58%
ZIOPHARM Oncology, Inc. Balance Sheet 2011-2024 | ZIOP
Annual Balance Sheet ZIOPHARM Oncology, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-110 M | -77.4 M | -61.7 M | -70.9 M | -81.1 M | -141 M | -42.8 M | -68.2 M | -73.3 M | -105 M |
Long Term Debt |
4 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
4 M | 1.58 M | 4 K | 37.6 M | 42.5 M | 48.2 M | 570 K | 14.6 M | 16.1 M | 23.1 M |
Total Current Liabilities |
18.4 M | 12.5 M | 9.48 M | 20.9 M | 15.8 M | 18.1 M | 10.8 M | 7.79 M | 18.9 M | 13.4 M |
Total Liabilities |
22.4 M | 14.1 M | 9.49 M | 58.4 M | 58.3 M | 66.4 M | 11.4 M | 22.4 M | 35 M | 36.5 M |
Deferred Revenue |
- | - | - | 6.39 M | 6.39 M | 6.86 M | 1.36 M | 800 K | 800 K | 815 K |
Retained Earnings |
-764 M | -684 M | -566 M | -712 M | -658 M | -493 M | -373 M | -341 M | -284 M | -188 M |
Total Assets |
146 M | 109 M | 95.1 M | 106 M | 106 M | 154 M | 45.2 M | 71.8 M | 83.4 M | 108 M |
All numbers in USD currency